Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Pricing your quoteWhy Your RFP Pricing Strategy Is Costing You
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More manufacturing bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Isoniazid and Rifampin

U.S. Department Of Health And Human Services·Maryland

Isoniazid and Rifampin

Closes 4/21/2026$500k – $2MRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Health and Human Services, DHHS, Supply Service Center (SSC) is seeking sources for Isoniazid and Rifampin tablets. The quantities required are 7,500 bottles of Isoniazid, 300 mg, 30s, and 7,500 bottles of Rifampin, 300 mg, 60s. • The opportunity requires the supply of pharmaceutical products, specifically Isoniazid and Rifampin tablets. • The quantities required are large, indicating a significant need for these products. • The opportunity is likely to be of interest to pharmaceutical manufacturers or suppliers who can provide the required quantities of Isoniazid and Rifampin tablets.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Tim Bouchelle

[email protected]

(443) 947-6039

Key dates

Opened
4/7/2026
Closes
4/21/2026

Last updated

Details

Type
Request for Quotation
Industry
Manufacturing
NAICS
3254
Solicitation №
IandR

Budget estimate

$500,000 – $2,000,000

The budget for this opportunity is likely to be significant, given the large quantities of Isoniazid and Rifampin tablets required. The cost of these pharmaceutical products will depend on various factors, including the manufacturer, the quality of the products, and the delivery terms. A rough estimate for the cost of these products could be around $500,000 to $2 million, considering the quantities required and the average cost of pharmaceutical products. However, this is a very rough estimate and the actual budget could be higher or lower, depending on the specifics of the opportunity and the bidding process.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Health And Human Services·Maryland

Top match · 56%

Reagents and consumables for Roche immunostainers

Closes 11/16/2026Opened 10/30/2026

U.S. Department Of Defense·Pennsylvania

55% match

Bicalutamide Tablets

Closes 11/1/2026Opened 9/2/2026

U.S. Department Of Defense·United States of America

55% match

Bicalutamide Tablets

Closes 11/1/2026Opened 9/2/2026

U.S. Department Of Health And Human Services·United States of America

55% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

54% match

Improved Drug Susceptibility Testing (DST) for Mycobacteria

Closes 5/27/2027Opened 6/24/2026

U.S. Department Of Health And Human Services·United States of America

54% match

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Closes 11/20/2026Opened 10/29/2026

U.S. Department Of Defense·Vermont

54% match

Rivastigmine 24HR Patches

Closes 9/14/2028Opened 9/30/2021

U.S. Food and Drug Administration·United States of America

53% match

Novel approaches to support therapeutic development in ultra-rare cancers

Rolling / TBD closeOpened 8/4/2025

U.S. Food and Drug Administration·United States of America

53% match

Minor Use Minor Species Development of Drugs (R01)

Rolling / TBD closeOpened 11/30/2023

U.S. Food and Drug Administration·United States of America

53% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Defense·Florida

53% match

Ibuprofen 400MG/600MG/800MG Tablets

Closes 2/12/2029Opened 2/15/2023

U.S. National Institutes of Health·United States of America

53% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

Corrections and Community Supervision, NYS Dept. of·New York

53% match

Controlled, Legend and OTC Medications

Closes 11/5/2026Opened 9/29/2026

U.S. National Institutes of Health·United States of America

53% match

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Closes 11/18/2027Opened 11/20/2024

U.S. Food and Drug Administration·United States of America

53% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Defense·United States of America

53% match

Famotidine

Closes 8/2/2028Opened 9/27/2022

U.S. Department Of Health And Human Services·United States of America

52% match

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Closes 11/20/2026Opened 10/29/2026

U.S. Department Of Defense·Pennsylvania

52% match

Methylphenidate ER

Closes 11/6/2026Opened 9/23/2026

City of Pasadena·California

52% match

Purchase of Antibiotics

Closes 11/4/2026Opened 10/15/2026

U.S. National Institutes of Health·United States of America

52% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

52% match

Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)

Closes 11/10/2026Opened 3/3/2026

U.S. Department Of Defense·Indiana

52% match

Pantoprazole DR Tablets

Closes 1/26/2028Opened 6/10/2021